Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative lidocaine infusion for postoperative ileus after laparoscopic colorectal surgery
ACTRN12619001168145Phase 3Not yet recruiting
- Sponsor
- Dr Rebecca Shine
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative ileus (POI) comparing Postoperative lidocaine infusion with Placebo infusion (2 arms). Primary endpoint: Return of gastrointestinal function. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ACTRN12619001168145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001168145.